APA (7th ed.) Citation

NH, Z., D, H., MH, S., N, H., A, E., & E, T. (2023). Genetic mutations in HER2-positive breast cancer: Possible association with response to trastuzumab therapy. Human genomics, 17(1), 43. https://doi.org/10.1186/s40246-023-00493-5

Chicago Style (17th ed.) Citation

NH, Zakaria, Hashad D, Saied MH, Hegazy N, Elkayal A, and Tayae E. "Genetic Mutations in HER2-positive Breast Cancer: Possible Association with Response to Trastuzumab Therapy." Human Genomics 17, no. 1 (2023): 43. https://doi.org/10.1186/s40246-023-00493-5.

MLA (9th ed.) Citation

NH, Zakaria, et al. "Genetic Mutations in HER2-positive Breast Cancer: Possible Association with Response to Trastuzumab Therapy." Human Genomics, vol. 17, no. 1, 2023, p. 43, https://doi.org/10.1186/s40246-023-00493-5.